Search Results

There are 4514 results for: content related to: Indinavir and nelfinavir inhibit proximal insulin receptor signaling and salicylate abrogates inhibition: Potential role of the NFkappa B pathway

  1. pH-dependent interactions of indinavir and lipids in nanoparticles and their ability to entrap a solute

    Journal of Pharmaceutical Sciences

    Volume 97, Issue 2, February 2008, Pages: 931–943, Sung-Up Choi, Tot Bui and Rodney J.Y. Ho

    Version of Record online : 1 JUN 2007, DOI: 10.1002/jps.21020

  2. Indinavir and Rifabutin Drug Interactions in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 44, Issue 3, March 2004, Pages: 305–313, Dr Walter K. Kraft, Dr Jacqueline B. McCrea, Dr Gregory A. Winchell, Dr Alexandra Carides, Mr Richard Lowry, Dr Eric J. Woolf, Ms Sandra E. Kusma, Dr Paul J. Deutsch, Dr Howard E. Greenberg and Dr Scott A. Waldman

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003262807

  3. Population pharmacokinetic analysis of indinavir in HIV-infected patient treated with a stable antiretroviral therapy

    Fundamental & Clinical Pharmacology

    Volume 19, Issue 3, June 2005, Pages: 373–383, Karl Brendel, Mayeule Legrand, Anne-Marie Taburet, Gabriel Baron, Cécile Goujard, France Mentré and the Cophar 1-ANRS 102 Trial Group

    Version of Record online : 20 JAN 2005, DOI: 10.1111/j.1472-8206.2005.00315.x

  4. You have free access to this content
    The antiretroviral protease inhibitors indinavir and nelfinavir stimulate Mrp1-mediated GSH export from cultured brain astrocytes

    Journal of Neurochemistry

    Volume 120, Issue 1, January 2012, Pages: 78–92, Maria Brandmann, Ketki Tulpule, Maike M. Schmidt and Ralf Dringen

    Version of Record online : 11 NOV 2011, DOI: 10.1111/j.1471-4159.2011.07544.x

  5. You have free access to this content
    Reduced indinavir exposure during pregnancy

    British Journal of Clinical Pharmacology

    Volume 76, Issue 3, September 2013, Pages: 475–483, Tim R. Cressey, Brookie M. Best, Jullapong Achalapong, Alice Stek, Jiajia Wang, Nantasak Chotivanich, Prapap Yuthavisuthi, Pornnapa Suriyachai, Sinart Prommas, David E. Shapiro, D. Heather Watts, Elizabeth Smith, Edmund Capparelli, Regis Kreitchmann, Mark Mirochnick and for the IMPAACT P1026s team

    Version of Record online : 20 AUG 2013, DOI: 10.1111/bcp.12078

  6. The steady-state disposition of indinavir is not altered by the concomitant administration of clarithromycin

    Clinical Pharmacology & Therapeutics

    Volume 67, Issue 4, April 2000, Pages: 351–359, Susan E. Boruchoff, Marc G. Sturgill, Kenneth W. Grasing, James R. Seibold, Jackie McCrea, Gregory A. Winchell, Sandra E. Kusma and Paul J. Deutsch

    Version of Record online : 11 APR 2000, DOI: 10.1067/mcp.2000.105151

  7. You have free access to this content
    Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus

    British Journal of Clinical Pharmacology

    Volume 65, Issue 5, May 2008, Pages: 667–673, Sreeja Sudhakaran, Craig R. Rayner, Jian Li, David C. M. Kong, Neil M. Gude and Roger L. Nation

    Version of Record online : 18 DEC 2007, DOI: 10.1111/j.1365-2125.2007.03067.x

  8. Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection

    Clinical Pharmacology & Therapeutics

    Volume 68, Issue 4, October 2000, Pages: 367–374, David W. Haas, Julie Stone, Lisa A. Clough, Benjamin Johnson, Paul Spearman, Victoria L. Harris, Janet Nicotera, Regina H. Johnson, Stephen Raffanti, Ling Zhong, Paul Bergqwist, Steven Chamberlin, Vicki Hoagland and William D. Ju

    Version of Record online : 29 OCT 2000, DOI: 10.1067/mcp.2000.109391

  9. You have free access to this content
    Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir-binding site

    European Journal of Biochemistry

    Volume 271, Issue 8, April 2004, Pages: 1516–1524, Bhuvaneshwari Mahalingam, Yuan-Fang Wang, Peter I. Boross, Jozsef Tozser, John M. Louis, Robert W. Harrison and Irene T. Weber

    Version of Record online : 1 APR 2004, DOI: 10.1111/j.1432-1033.2004.04060.x

  10. You have free access to this content
    Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease

    Protein Science

    Volume 11, Issue 2, February 2002, Pages: 418–429, Nancy M. King, Laurence Melnick, Moses Prabu-Jeyabalan, Ellen A. Nalivaika, Shiow-Shong Yang, Yun Gao, Xiaoyi Nie, Charles Zepp, Donald L. Heefner and Celia A. Schiffer

    Version of Record online : 13 APR 2009, DOI: 10.1110/ps.25502

  11. You have free access to this content
    Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients

    British Journal of Clinical Pharmacology

    Volume 60, Issue 3, September 2005, Pages: 276–286, Bregt S. Kappelhoff, Alwin D. R. Huitema, Sanjay U. C. Sankatsing, Pieter L. Meenhorst, Eric C. M. Van Gorp, Jan W. Mulder, Jan M. Prins and Jos H. Beijnen

    Version of Record online : 29 JUN 2005, DOI: 10.1111/j.1365-2125.2005.02436.x

  12. You have free access to this content
    No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 56, Issue s1, December 2003, Pages: 62–68, Lynn Purkins, Nolan Wood, Diane Kleinermans and Edward R. Love

    Version of Record online : 17 NOV 2003, DOI: 10.1046/j.1365-2125.2003.02001.x

  13. You have free access to this content
    Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients

    British Journal of Clinical Pharmacology

    Volume 64, Issue 3, September 2007, Pages: 353–362, Caroline Solas, Nicolas Simon, Marie-Pierre Drogoul, Sylvie Quaranta, Véronique Frixon-Marin, Véronique Bourgarel-Rey, Corinne Brunet, Jean-Albert Gastaut, Alain Durand, Bruno Lacarelle and Isabelle Poizot-Martin

    Version of Record online : 22 MAY 2007, DOI: 10.1111/j.1365-2125.2007.02903.x

  14. You have free access to this content
    The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans

    FEMS Immunology & Medical Microbiology

    Volume 42, Issue 2, October 2004, Pages: 187–195, Elisabetta Blasi, Bruna Colombari, Carlotta Francesca Orsi, Marcello Pinti, Leonarda Troiano, Andrea Cossarizza, Roberto Esposito, Samuela Peppoloni, Cristina Mussini and Rachele Neglia

    Version of Record online : 9 JAN 2006, DOI: 10.1016/j.femsim.2004.05.001

  15. Pharmacokinetic Interaction Study of Indinavir/Ritonavir and the Enteric-Coated Capsule Formulation of Didanosine in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 45, Issue 2, February 2005, Pages: 211–218, C. la Porte, C. Verweij-van Wissen, N. van Ewijk, R. Aarnoutse, P. Koopmans, P. Reiss, M. Stek Jr, Y. Hekster and D. Burger

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004271063

  16. Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen – ANRS 111 trial

    Fundamental & Clinical Pharmacology

    Volume 23, Issue 4, August 2009, Pages: 491–500, Xavier Duval, France Mentré, Elisabeth Rey, Solange Auleley, Gilles Peytavin, Michel Biour, Annie Métro, Cecile Goujard, Anne-Marie Taburet, Cecile Lascoux, Xaviere Panhard, Jean-Marc Tréluyer, Dominique Salmon-Céron and the Cophar 2 study group

    Version of Record online : 30 JUL 2009, DOI: 10.1111/j.1472-8206.2009.00693.x

  17. Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers

    Clinical Pharmacology & Therapeutics

    Volume 78, Issue 2, August 2005, Pages: 143–153, Marshall J. Glesby, Judith A. Aberg, Michelle A. Kendall, Carl J. Fichtenbaum, Richard Hafner, Stephen Hall, Nicole Grosskopf, Andrew R. Zolopa and John G. Gerber

    Version of Record online : 11 AUG 2005, DOI: 10.1016/j.clpt.2005.04.005

  18. Kinetics and mechanism of the hydrolytic degradation of indinavir: Intramolecular catalysis

    Journal of Pharmaceutical Sciences

    Volume 97, Issue 9, September 2008, Pages: 3810–3819, Maria M. Toteva, Roger Zanon and Drazen Ostovic

    Version of Record online : 10 JAN 2008, DOI: 10.1002/jps.21259

  19. You have free access to this content
    Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases

    International Journal of Cancer

    Volume 128, Issue 1, 1 January 2011, Pages: 82–93, Elena Toschi, Cecilia Sgadari, Laura Malavasi, Ilaria Bacigalupo, Chiara Chiozzini, Davide Carlei, Daniela Compagnoni, Stefania Bellino, Roberto Bugarini, Mario Falchi, Clelia Palladino, Patrizia Leone, Giovanni Barillari, Paolo Monini and Barbara Ensoli

    Version of Record online : 27 OCT 2010, DOI: 10.1002/ijc.25550

  20. Effect of Semen Sampling Frequency on Seminal Antiretroviral Drug Concentration

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 6, June 2008, Pages: 848–856, YJ Cao, TT Ndovi, TL Parsons, AM Guidos, B Caffo and CW Hendrix

    Version of Record online : 3 OCT 2007, DOI: 10.1038/sj.clpt.6100356